Our fair value estimate for Recruit is JPY 7,700 per share, implying a price/earnings ratio of 29 on our fiscal 2024 estimates. We use a weighted average cost of capital, or WACC, of 8%, reflecting ...
More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback